CashNews.co
Snowflake’s year-to-date stock performance.
Snowflake: “…It’s kind of like the long knives are out for those guys right now. I think I’m going to hold off from recommending it.”
Royalty Pharma’s year-to-date stock performance.
Royalty Pharma: “I always thought there was going to be more to this stock than there has been. It’s really been a bit of a bust…It’s just a so-so situation.”
Core Scientific’s year-to-date stock performance.
Core Scientific: “Core Scientific is a very overvalued situation, principally because of the fact that it’s never made any money. But it is another play on crypto. If you like crypto, buy crypto.” “
Ally Financial’s year-to-date stock performance.
#cashnews #UnitedStates #newsfinace #finance #FollowsCashnews